CD8A and melanoma: In a mouse model of B16 melanoma that has a high abundance of FAs, promoting β-oxidation in CD8 T cells was shown to improve T cell polyfunctionality and act in synergy with anti-PD-1 therapy to efficiently delay tumor growth [3].